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Abstract
Introduction: The need for parathyroidectomy remains high in the group of patients on long-term dialysis with medically refractory 
secondary hyperparathyroidism (sHPT). We aim to compare the results after subtotal parathyroidectomies (sPtx) and total parathyroid-
ectomies with autotransplant (tPtx + AT) performed for sHPT at a single referral centre. 
Material and methods: This prospective study comparatively analysed sPtx and tPtx + AT performed in our department between Feb-
ruary 2010 and December 2014. We followed-up both surgical techniques, with respect to the main clinical symptoms, laboratory data, 
mortality, and recurrent disease. 
Results: Forty-three patients on whom we performed 26 sPtx and 19 tPtx + AT were entered in the study. There were no statistically 
significant differences between groups as far as demographic and preoperative clinical data are concerned. We did not encounter post-
operative mortality in either of the groups. The follow-up period was significantly longer for the sPtx group (p = 0.04). The immediate 
postoperative serum calcium levels were significantly lower in the tPtx + AT group (p = 0.009). Definitive hypoparathyroidism was 
encountered in two patients in the sPtx group (8.3%) and in one from the tPtx + AT group (5.26%). Four patients from the sPtx group 
(16.6%) and three from the tPtx + AT group (15.78%) died during the follow-up due to causes unrelated to parathyroidectomy. Overall 
we had two recurrences in the sPtx group and none in the tPtx + AT group (p = 0.57).
Conclusions: In our opinion both techniques have comparable results concerning the clinical and laboratory outcomes and rates of post-
operative hypoparathyroidism, at least in short- and medium-term follow-up. (Endokrynol Pol 2016; 67 (2): 202–209)
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Streszczenie
Wstęp: Potrzeba wykonywania zabiegu usunięcia przytarczyc pozostaje na wysokim poziomie wśród grupy pacjentów poddawanych 
długoterminowej dializie cierpiących na wtórną nadczynność przytarczyc (sHPT) oporną na leczenie. W niniejszym badaniu, autorzy 
porównują wyniki po częściowym usunięciu przytarczyc (sPtx) oraz całkowitym ich usunięciu z autoprzeszczepem (tPtx + AT) wykona-
nym dla sHPT w jednym ośrodku referencyjnym. 
Materiał i metody: Niniejsze prospektywne badanie dokonuje analizy porównawczej sPtx oraz tPtx + AT, wykonanych w miejscu pracy 
autorów w okresie od lutego 2010 do grudnia 2014 roku. Autorzy porównali obie techniki operacyjne w związku z głównymi objawami 
klinicznymi, badaniami laboratoryjnymi, śmiertelnością oraz nawrotowością choroby.
Wyniki: W badaniu wzięło udział 43 pacjentów: 26 poddano sPtx, a 19 tPtx + AT. Pomiędzy grupami nie było znaczących różnic staty-
stycznych, jeśli chodzi o dane demograficzne i przedoperacyjne dane kliniczne. Nie stwierdzono śmiertelności pooperacyjnej w żadnej 
z grup. Okres obserwacji trwał zdecydowanie dłużej w grupie sPtx (p = 0,04). Stężenie wapnia w osoczu mierzone zaraz po operacji 
było znacznie niższe w grupie tPtx + AT (p = 0,009). Całkowita niedoczynność przytarczyc zidentyfikowano u dwóch pacjentów 
w grupie sPtx (8,3%) oraz jednego z drugiej grupy (5,26%). Czterech pacjentów z grupy sPtx (16,6%) i trzech z grupy tPtx + AT (15,78%) 
zmarło podczas okresu obserwacji z powodów niezwiązanych z usunięciem przytarczyc. Ogółem zidentyfikowano dwa nawroty choroby 
w grupie sPtx i żadnego z drugiej grupie (p = 0,57).
Wnioski: W opinii autorów, obie techniki dają porównywalne wyniki, biorąc pod uwagę wyniki laboratoryjne oraz kliniczne, a także 
wskaźniki pooperacyjnej niedoczynności przytarczyc, przynajmniej w krótko- i średnioterminowym okresie obserwacji. 
(Endokrynol Pol 2016; 67 (2): 202–209)
Słowa kluczowe: częściowe usunięcie przytarczyc; całkowite usunięcie przytarczyc; autoprzeszczep
This paper was done under the frame of University of Medicine and Pharmacy Tg Mures, Romania, by the Project number 14439 from 15.10.2014.
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cluded patients with severe, medically refractory sHPT, 
who underwent either sPtx or tPtx + AT during the 
aforementioned period and were followed-up at least 
three months after the surgery. Our inclusion criteria 
for parathyroidectomy were: very high levels of intact 
parathyroid hormone (iPth > 800 pg/mL) unresponsive 
to available medical therapy; severe clinical symptoms 
such as osteoarticular pains, pruritus, and muscle 
weakness; radiological findings indicating severe os-
teoporosis, bone changes, or osteitis fibrosa cystica; and 
high levels of serum calcium and phosphorus (serum 
calcium-phosphate production over 70 mg/dL). We 
excluded from the present study patients submitted to 
total parathyroidectomy without autotransplantation 
and those with a follow-up period under three months, 
no matter the type of surgery.
The diagnosis was established on laboratory and 
imagistic data. Preoperative localisation studies in-
cluded neck ultrasonography and Tc-99m sestamibi 
parathyroid scans, the latter being inconstantly used. 
All patients were loaded with vitamin D and were 
dialysed the day before the operation, the next dialysis 
being done on the first postoperative day. All patients 
were informed about the aim of this study and provided 
written informed consent, and the study was done with 
the consent of the Hospital Ethics Committee.
Surgical procedures
The treatment options for the studied cohort were 
sPtx and tPtx + AT, both surgeries being performed 
under general anaesthesia. As a general principle we 
constantly dissect the recurrent laryngeal nerves at the 
beginning of both procedures. We did not routinely 
perform thymectomy if four parathyroid glands were 
confidently identified. Subtotal parathyroidectomies 
were performed by leaving one third to one fourth of 
a cvasinormal well-vascularised inferior gland with 
its neopedicle (small mediastinal or thymic vessels) in 
a suprasternal position. Total parathyroidectomies with 
autotransplant were performed by implanting 9–15 
small pieces (1 mm3) of non-nodular parathyroid tis-
sues in 3–4 muscular pockets of sternocleidomastoid 
muscle, marked with a metallic clip. In a few cases we 
encountered associated thyroid pathology requiring 
lobectomies or total thyroidectomies. All parathyroid 
glands were weighed, measured, and sent for patho-
logical testing.
Postoperative management and follow-up
All patients who underwent both procedures were 
carefully evaluated before parathyroidectomy in terms 
of clinical data, laboratory parameters, and results of 
localisation studies. The first postoperative dialysis 
was performed on postoperative day 1. In the first 
Introduction
Secondary hyperparathyroidism (sHPT), frequently 
encountered among patients with end-stage renal 
disease (ESRD) on haemodialysis, is a potentially 
severe complication that can lead to metabolic bone 
disease and severe cardiovascular events [1]. In spite 
of improved conventional medical therapy, the need 
for parathyroidectomy remains high, especially in the 
group of patients on long-term dialysis with medically 
refractory sHPT [2, 3]. Among surgical indications in 
sHPT few are generally accepted, i.e. worsening clinical 
symptoms under correct medical therapy, high values 
of serum intact parathyroid hormone (iPth) and phos-
phorus, calciphylaxis, and osteitis fibrosa cystica [4, 5].
The optimal surgical procedure in sHPT treatment is 
far from established, this issue being under continuous 
controversy in literature. The remnant-conserving tech-
niques of parathyroidectomy consist of either subtotal 
parathyroidectomy (sPtx) —removing all parathyroid 
tissue but a small portion of a normal appearing gland 
which is left in the neck or total parathyroidectomy with 
autotransplant (tPtx + AT) — removing all parathyroid 
tissue and reimplanting at a distance small pieces of 
tissue in well-vascularised muscular structures. Even 
if both techniques are now under intense criticism, 
mainly due to their high recurrence rates of sHPT, they 
remain the most recommended and widely performed 
surgical procedures [1, 3]. Recently another technique, 
total parathyroidectomy without autotransplant (tPtx), 
re-emerged as a trustworthy surgical solution in severe 
sHPT, especially in patients with low perspective for 
renal transplantation [1, 3, 6]. 
The present study comparatively analyses a series 
of patients who underwent sPtx or tPtx + AT at a single 
referral centre. Our aim was to evaluate and compare 
the short-, medium-, and long-term follow-up results 
after both surgical techniques, with respect to the main 
clinical symptoms, laboratory data, mortality, and re-
current disease and to define a surgical strategy in our 
daily practice. 
Material and methods
This is a prospective study of a cohort of patients with 
ESRD on haemodialysis, submitted to parathyroid-
ectomy for severe sHPT between February 2010 and 
December 2014 at the Second Department of General 
Surgery, the University of Medicine and Pharmacy 
Tîrgu Mures. During this period we performed three 
types of surgeries: sPtx, tPtx + AT, and total parathy-
roidectomy without autotransplantation (tPtx). All 
surgeries were done by the same surgical team and the 
initial experience was previously reported [7, 8]. We in-
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postoperative weeks we carefully monitored calcium 
levels and, when considered appropriate, calcium 
gluconate infusion with oral alphacalcidol was admin-
istered. In the follow-up period we evaluated patients 
at three-month intervals as regards improvement of 
symptoms, iPth, total calcium, phosphate, and alkaline 
phosphatase (AlkPhos) serum levels. We considered as 
a short follow-up the first six postoperative months, and 
as a medium follow-up the next 6-18 months; after this 
time frame we defined the long-term follow-up period. 
Three patients from our group were lost to follow-up. 
Hypoparathyroidism was considered when iPth levels 
remained constantly low (under 12 pg/mL) one year 
after parathyroidectomy, with normal or low serum 
calcium levels under appropriate supplementation. 
We defined persistent or recurrent HPT according to 
the National Kidney Foundation’s Kidney Disease 
Outcomes Quality Initiative (K-DOQI) [9].
Statistical analysis
All statistical calculations were performed using Graph 
Pad Software, San Diego, California, USA. We tested 
the normal distribution for continuous variable using 
Kolmogorov-Smirnov test. We characterised them as 
mean and standard deviation of the mean (SD) for vari-
ables with normal distribution, or as median and 25–75 
percentiles for variables with abnormal distribution. 
We chose adequate statistical tests according to data 
distribution. The frequencies of nominal variables were 
compared with the chi-square test. Differences between 
mean age values were determined by Student t-test. 
Differences in values between compared postoperative 
variables were determined by Kruskal-Wallis test (as-
sociated with the Dunns multiple comparison test) and 
ANOVA test (associated with the Bonferroni multiple 
comparison test). All the tests were interpreted relative 
to the significance threshold p = 0.05, and statistical 
significance was considered for p-values below the 
significance threshold value.
Results
Forty-three patients on whom we performed 
45 parathyroidectomies were entered in the study. The 
general cohort was divided into two groups: a sPtx 
group, including 24 patients (55.81%) with a mean age 
± SD of 50.0 ± 10.6 years, on whom we performed 
26 parathyroid surgeries and a tPtx + AT group of 
19 patients (44.18%) with a mean age ± SD of 51.1 ± 11.1 
years. There were no statistically significant differences 
between groups as far as demographic, causes of ESRD 
and preoperative clinical data are concerned (Table I).
Patients presented with various clinical symptoms, 
but the main complaints were arthralgia, myalgia and 
bone pains, muscle weakness, and pruritus. We had 
one female patient in the sPtx group, who presented 
Table I. Demographic and clinical data of the studied patients
Tabela I. Dane demograficzne i kliniczne pacjentów ujętych w badaniu
sPtx  
(n = 24)
tPtx + AI 
(n = 19)
p value
Sex (males/females), no (%)# 8 (33.3)/16 (66.7) 9 (47.4)/10 (52.6) 0.53
Age (years), mean ± SD* 50.0 ± 10.6 51.1 ± 11.1 0.72
Dialytic age (years), mean ± SD* 8.35 ± 2.5 9.14 ± 2.7 0.32
Preoperative iPth [pg/mL] 
Median (min–max)**
2131  
(1141–10000)
2439  
(840–6115)
0.88
Preoperative total serum calcium [mg/dL], mean ± SD* 9.02 ± 0.84 9.50 ± 0.51 0.17
Preoperative serum phosphorus [mg/dL], mean ± SD* 5.86 ± 1.31 6.17 ± 0.76 0.35
Preoperative AlkPhos [U/L], 
Median (min–max)**
575.0  
(196.1–2636)
587.0  
(84–987.0)
0.80
Associated thyroid pathology, n (%)# 4 (16.6) 3 (15.8) 0.73
In hospital stay(days) 
Median (min–max)**
4 
(2–9)
3 
(2–6)
0.24
Persistent hyperparathyroidism 2 (8.3) 0 (0.0) 0.57
Follow–up (months) 
Median (min–max)**
38 
(6–52)
18 
(1–36)
0.03
Recurrent sHPT, n (%)# 2 (8.3) 0 (0.0) 0.57
Deaths during follow–up, n (%)# 4 (16.6) 3 (15.7) 0.73
#chi square test; *data expressed as mean ± SD, Student test; **data expressed as median (min–max), Mann Whitney test
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multiple osseous lesions consistent with brown tu-
mours, including an extremely rare multilevel spine 
localisation (Fig. 1A, B). She had a massively raised 
preoperative serum iPth level (10 000 pg/mL) showing 
a severe secondary hyperparathyroid status, unrespon-
sive to medical treatment. We also noted calcification 
or deposits of calcium in soft tissues in some patients. 
Patients from both groups had markedly elevated 
preoperative serum iPth, with median values above 
2000 pg/mL. We also frequently noted hypophospha-
taemia and high levels of AlkPhos, without significant 
differences between groups; not all of our patients had 
elevated preoperative calcium levels.
Regarding preoperative imaging studies, both cer-
vical ultrasonography and 99mTc sestamibi failed to 
identify all enlarged parathyroids. In the last period we 
performed only cervical ultrasonography as a routine 
preoperative localisation study, 99mTc sestamibi being 
considered only for reinterventions.
Associated thyroid pathology was encountered in 
seven patients from both groups. Two total thyroidec-
tomies (TT) and two lobectomies where performed in 
the sPtx group, while two TT and one lobectomy were 
done in the second group. We had one patient in the 
sPtx group with a TT for a multinodular goitre in whom 
the final histopathological report revealed a papillary 
microcarcinoma. In the other group we encountered 
a patient with a papillary thyroid carcinoma; here we 
performed TT and an ipsilateral central compartment 
lymphadenectomy.
We did not encounter postoperative mortality in ei-
ther group; in the sPtx group we noted two patients with 
temporally dysphonia after operation and one cervical 
haematoma after the first postoperative dialysis, requir-
ing surgical evacuation. In the immediate postoperative 
period (30 days) seven patients (29.16%) from this group 
presented minor episodes of hypocalcaemia (“hungry 
bones” syndrome), rapidly restored after calcium in-
fusions. In the same group we also had two cases of 
persistent hyperparathyroidism (immediate iPth values 
> 300 pg/mL), both with only three parathyroids ini-
tially resected. One patient was reoperated on after two 
months when we found a fourth (missed) inferior para-
thyroid in the anterior mediastinum. The second patient 
also had a repeated neck exploration; here a left superior 
gland was found in an upper retroesophageal ectopy. 
This latter patient subsequently developed a postopera-
tive hypoparathyroidism, with iPth values constantly 
below 10 pg/mL, but with a moderate hypocalcaemia and 
no related clinical symptoms. In the tPtx + AT group we 
did not encounter persistent hyperparathyroidism cases; 
here we had one case of temporary dysphonia and nine 
patients (47.36%) with postoperative hypocalcaemia. 
The average length of in-hospital stay was four days 
(range 2–9 days) in the sPTx group and three days (range 
2–6 days) in the tPtx + AT group. 
Figure 1A. Sagittal T2 weighted sequence of the thoracic and lumbar spine shows at the level of the body of Th 10th an expansile lesion 
with heterogenous signal. B. Axial T2-weighted image at the level of Th 10th, brown tumour of the body of Th 10th vertebrae
Rycina 1A. Obraz T2-zależny kręgosłupa w odcinku piersiowym i lędźwiowym w projekcji strzałkowej pokazuje na poziomie dziesiątego 
kręgu piersiowego rozległą zmianę o heterogenicznym sygnale. B. Obraz T2-zależny w projekcji osiowej pokazuje guz barwy brązowej 
na poziomie dziesiątego kręgu piersiowego
A B
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The median follow-up period was significantly 
longer for the sPtx group than for the tPtx + AT group 
(38 months vs. 18 months, respectively); three patients 
from the sPtx group were lost to follow-up. All the rest 
were carefully evaluated at three-month intervals in 
terms of clinical symptoms and biochemical parameters. 
Sequential values of iPth, serum calcium, phosphorus, 
and AlkPhos during follow-up for both groups are 
presented in Table II.
The serum iPth levels decreased significantly in both 
groups when compared with preoperative values, but 
without postoperative differences between them. The 
severe hyperparathyroidism was corrected in 100% 
of patients in the tPtx + AT group and in 91.6% in the 
other group. The only significant difference between 
groups was in immediate (one-month) postoperative 
serum calcium levels, which were significantly lower 
in the tPtx + AT group, with a mean ± SD value of 
7.56 ± 0.96 in this group and 8.47 ± 1.16 in the sPtx group 
(p = 0.009). Indeed, in the tPtx + AT group we had 
four patients who had serum calcium below 7 mg/dL 
in the first postoperative month and symptoms related 
Table II. Sequential values for of iPth, serum calcium, phosphorus and AlkPhos during follow-up for both groups; values are 
calculated for short (under 6 months), medium (6–18 months), and long-term follow-up (over 18 months)
Tabela II. Wartości sekwencyjne dla iPth, wapnia w osoczu, fosforu i fosfatazy alkalicznej w okresie obserwacji dla obu grup; 
wartości liczone są dla krótkiego (poniżej 6 miesięcy), średniego (6–18 miesięcy) oraz długiego okresu obserwacji (powyżej 
18 miesięcy)
Variables sPtx 
(n = 24) 
tPtx + AI  
(n = 19) 
P value
Ca (1 month) [mg/dL] 
mean ± SD*
8.47 ± 1.16 7.56 ± 0.96 0.009
Ca (short) [mg/dL] 
mean ± SD*
8.21 ± 1.21 7.84 ± 0.55 0.22
Ca (medium) [mg/dL] 
mean ± SD*
8.62 ± 0.91 8.26 ± 0.61 0.21
Ca (long) [mg/dL] 
mean ± SD*
8.68 ± 0.80 8.66 ± 0.74 0.96
P (1 month) [mg/dL] 
mean ± SD*
3.91 ± 1.61 3.25 ± 0.61 0.10
P (short) [mg/dL] 
mean ± SD*
4.37 ± 1.34 3.68 ± 0.78 0.05
P (medium) [mg/dL] 
mean ± SD*
5.32 ± 1.21 4.11 ± 1.21 0.01
P (long) [mg/dL] 
mean ± SD*
5.38 ± 1.17 4.86 ± 1.14 0.32
iPTH (1 month) [pg/mL] 
median (min–max)**
28 (3–1263) 20 (9–68) 0.77
iPTH (short) [pg/mL] 
median (min–max)**
23.7 (0.8–86.7) 36.6 (14–78.15) 0.10
iPTH (medium) [pg/mL] 
median (min–max)**
19.5 (3–199.3) 38.1 (14.3–107.8) 0.03
iPTH (long) [pg/mL] 
median (min–max)**
45.3 (3–724.6) 61.2 (4.2–100.7) 0.85
AlkPhos (1 month) [U/I] 
median (min–max)**
452 (123–2236) 365 (78–767) 0.20
AlkPhos (short) [U/I] 
median (min–max)**
204.6 (39.6–416.5) 170.5 (61–321.0) 0.29
AlkPhos (medium) [U/I] 
median (min–max)**
123.9 (68.5–390.7) 103.0 (81.5–165.0) 0.65
AlkPhos (long) [U/I] 
median (min–max)**
113.9 (58.5–291.2) 97 (81.5–315.0) 0.71
*Data expressed as mean ± SD Student test; **Data expressed as median (min–max), Mann Whitney test; short — follow-up under 6 months; medium — follow-up 
6-18 months; long — follow-up above 18 months
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to hypocalcaemia, requiring important supplementa-
tion with calcium infusions and vitamin D analogues. 
During follow-up the serum calcium levels were com-
parable between the analysed groups, being found in 
the normal range. Definitive hypoparathyroidism was 
encountered in two patients in the sPtx group (8.3%) 
and one from the other group (5.26%), all these patients 
having iPth values below 10 pg/mL after one year from 
parathyroidectomy, under proper treatment. Four 
patients from the sPtx group (16.6%) and three from 
the other group (15.78%) died during the follow-up 
due to causes unrelated to parathyroidectomy. One 
patient from the sPtx group, who died 28 months after 
the surgery, was diagnosed with sHPT recurrence, 
having an iPth level above 500 pg/mL, well tolerated 
under medication. Overall we had two recurrences in 
the sPtx group and none in the other group, but the 
differences were not statistically significant. Definitive 
histological examinations of the resected parathyroids 
showed different patterns of nodular hyperplasia, 
diffuse hyperplasia, or mixed aspects in both groups, 
without significant differences (Table III). 
Discussion
The need for parathyroidectomy increases with the time 
on dialysis and survival of patients with stage 5 chronic 
renal disease [2, 4]. In Eastern European countries the 
prevalence of renal replacement therapies and renal 
transplant incidence are still very low when compared 
to Western counterparts [8, 10]. Even if in Romania we 
frequently note patients on long-term haemodialysis, 
as far as we know the number of parathyroidectomies 
performed per annum is lower than anticipated [8]. 
Calcimimetics and other new therapeutic agents, i.e. 
phosphate binders and vitamin D analogues, have 
demonstrated efficacy in sHPT. The treatment with 
cinacalcet is expensive but is supported in our coun-
try through a National Health System program, thus 
an important number of patients benefited from it 
throughout their dialytic periodic; the lack of response 
or contraindications to the treatment are among indica-
tions for parathyroidectomy.
Three types of surgeries have been proposed in 
sHPT, two of them (i.e sPtx and tPtx + AT together with 
their variations) being grouped as remnant-conserving 
techniques [1]. The philosophy behind those techniques 
resides in the preservation of a normal or less modified 
(non-nodular) portion of a gland, which is abandoned 
in the neck or autotransplanted in well-vascularised 
muscular regions [11, 12]. The third technique, total 
parathyroidectomy without autotransplantation (tPtx), 
was initially severely criticised mainly for the long-term 
hypoparathyroidism induced and its consequences on 
bone metabolism [13]. Recent papers, however, have re-
vived tPtx as a trustworthy technique with comparable 
results in short- and medium-term follow-up [6, 14, 15].
The present study comparatively analysed two 
groups of patients submitted to sPtx or tPtx + AT in 
our surgical department. Both groups were similar as 
regards demographics, time on dialysis, or causes of 
ESRD. Our patients underwent parathyroidectomy 
because of refractory medical sHPT, a state in which 
excessive parathyroid hormone secretion no longer 
responds to conventional medical treatment, here 
including adequate dialysis [7]. 
The indications for parathyroidectomy are still de-
bated in the literature, but similarly to others [1, 4, 5] 
we consider generally accepted high iPth levels (above 
800 pg/mL), disabling clinical picture with osteoarticular 
pains and bone changes, pruritus, muscular weakness, 
along with hyperphosphataemia, and less commonly 
hypercalcaemia. This clinical and laboratory picture 
was constantly seen in both our groups. Undeniably 
we frequently noted increased even huge values of 
preoperative serum iPth, hyperphosphataemia and 
increased values of AlkPhos in response to intense 
bone metabolism. Thus, we had patients with severe 
bone changes, pathological fractures, and other aspects 
that characterised osteitis fibrosa cystica. As previously 
mentioned, this clinical picture corroborated with the 
constant discovery of “macroscopically” nodular glands 
during surgeries betraying the long evolution of the dis-
ease, its “tertialisation”, and even surgery delays [7, 8]. 
The role of localisation studies in sHPT diagnosis 
is also debatable. Even if scintigraphy (99mTc-MIBI) is 
Table III. Type of parathyroid hyperplasia in the resected parathyroids from both groups
Tabela III. Typ rozrostu przytarczyc w wyciętych przytarczycach w obu grupach
Type of parathyroid hyperplasia sPtx group (24 cases) tPtx + AT group (19 cases) P value
Nodular, n (%)# 14 (58.33) 11(57.89) 0.77
Diffuse, n (%)# 7 (29.16) 5 (26.31) 0.89
Mixed, n (%)# 3 (12.50) 3 (15.78) 0.87
#chi square test
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considered the best and most sensitive test [1, 3, 16], its 
role in locating all parathyroid glands before surgery 
is doubtful, being less important when compared with 
the surgeon’s experience [16]. Scintigraphy becomes 
important in redo procedures for relapsing or persis-
tent hyperparathyroidism, especially when associated 
with high-resolution cervical ultrasonography [1, 16]. 
We frequently used both imagistic techniques at the 
beginning of our experience (first 15–20 cases), but in 
spite of this we encountered two cases of persistent 
hyperparathyroidism in that period (missed glands), 
a fact which we interpret now as reflecting an inherent 
learning curve.
Subtotal parathyroidectomy was the first surgical 
technique described in the treatment of sHPT [11]. 
As we mentioned above, we preferred a “modified” 
sPtx in which we placed the chosen inferior para-
thyroid gland in a subcutaneous position preserving 
a vascular “neo-pedicle” (small mediastinal and thymic 
vessels). We then resected the gland subtotally, pre-
serving a remnant that has in principle the dimension 
of a normal parathyroid [7]. Regarding tPtx + AT we 
used the sternocleidomastoid muscle as receptor for 
autotransplantation in all cases. Even if this technique 
is criticised by some authors [1, 3], claiming the diffi-
culties in localisation of the neck transplant in cases of 
recurrent graft HPT, we favoured it due to its simplicity 
and rapidity. Nonetheless, we constantly mark the au-
totransplant regions with metallic clips, thereby facili-
tating a possible reintervention. Cervical thymectomy 
is favoured by some authors [3, 17] but is still far from 
being considered a standard of care in sHPT. As far as 
we know there is an ongoing randomised controlled 
trial (TOPAR PILOT-Trial), started in 2007, which aims 
to evaluate tPtx with or without thymectomy [9]. We 
did not routinely perform cervical thymectomy in our 
groups if four glands were confidently identified, an 
opinion also supported by others [18]. Furthermore, 
there are authors who consider the opportunity of 
a central compartment lymphadenectomy (CCL) in sHPT 
bearing in mind the frequency of supranumerary para-
thyroids in sHPT [3]. We did not consider central CCL 
as a routine procedure in either group. However, we 
performed an ipsilateral CCL in a patient with associ-
ated papillary thyroid carcinoma. We did not have the 
opportunity to use intraoperative parathyroid hormone 
(IOPTH) assessment in monitoring the surgery results, 
a procedure otherwise less straightforward for sHPT 
than for primary hyperparathyroidism. Instead we 
constantly determined immediate postoperative iPth 
values in the first week after the surgery. 
Generally, remnant-conserving techniques are as-
sociated with good clinical outcome and functional 
improvement [6, 19–21]. Regardless of the surgical 
procedure we noted a rapid improvement of clinical 
symptoms after both types of parathyroidectomies, 
mainly those that concerned bone pains, pruritus, and 
muscle weakness. After surgery iPth levels dropped 
significantly in both groups, without statistical differ-
ences. The only significant difference was related to 
the postoperative serum total calcium levels which, 
as expected, were lower in the tPtx + AT group. As 
a consequence, we encountered more patients with 
“hungry bone” syndrome in this latter group, requiring 
higher doses and prolonged administration of calcium 
infusions and alphacalcidol.
We did not encounter in-hospital mortality in either 
series; the postoperative surgery-related complications 
were minor and transitory in both groups. We did have 
two patients with persistent HPT in the sPTx group, 
both being reoperated on, initially with good postop-
erative outcome. One of these patients presented iPth 
values below 10 pg/mL a few months after reinterven-
tion, values which remained constantly low during 
follow-up, but without clinical symptoms. Hypoparath-
yroidism could be determined in this case by the “low 
quality” of the autotransplanted parathyroid tissue, 
harvested from a left superior parathyroid in a retroe-
sophageal ectopy and with important morphological 
changes. None of the patients in the tPtx + AT group 
had persistent HPT, a fact which may be interpreted 
as being related to the learning curve, those patients 
being operated later on in the time line of this study.
At the end of the study 30 patients (69.76%) were free 
from disease, three patients had sHPT recurrence, and 
three patients from the sPtx group were lost to follow-
up. Furthermore, seven patients (32.3%) from both 
groups died during follow-up, from different causes 
unrelated to parathyroidectomy. Undoubtedly the latter 
percentage is rather high when compared with other 
studies [22, 23], but it reflects the clinical reality in our 
region: patients on long-term dialysis, with advanced 
disease, and with low perspective of renal transplanta-
tion. Of interest, none of our patients was submitted to 
renal transplant during the analysed period.
Remnant-conserving techniques are generally relat-
ed to higher relapse rate, between 5–80% [1]; Rothmund 
et al. randomised 40 patients with sHPT to either sPtx 
or tPtx + AT, describing significantly less recurrences 
after the latter surgical technique [24]. In spite of this 
clear statistical conclusion, the study was to small to 
determine a standardisation of surgical approach in 
sHPT; furthermore, other retrospective studies, includ-
ing a meta-analysis of 53 publications regarding surgical 
treatment of sHPT, did not show significant differences 
between the two aforementioned techniques [3, 19]. Our 
recurrence rates were comparable in either group and 
rather low when compared with the above-mentioned 
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numbers; however, at least for the tPtx + AT group, 
the follow-up period was only 18 months, thus a clear 
conclusion is difficult to be drawn. It seems that tPtx 
has reappeared as a “rehabilitated” surgical technique, 
after a long period of controversial discussion [6, 14, 
16, 25, 26]. In the studied period we performed tPtx in 
few cases, generally in patients with severe and long 
lasting disease and without a realistic perspective of 
renal transplantation. Due to the low number of those 
patients they were excluded from the present analysis. 
Conclusions
Despite improvements in medical therapies, parathy-
roidectomy remains a solution in a subset of patients 
with severe refractory sHPT. Over the last decades, there 
has been considerable controversy as to which of the 
described parathyroidectomy approaches provide better 
short- and long-term outcomes, most of the conclusions 
being contradictory. In spite of its limitations — it is non-
randomised, with small sample size per arm and several 
group selection biases — we believe that our study 
reflects the reality regarding the clinico-therapeutic 
particularities of sHPT in our geographical area: patients 
on long-term dialysis, with advanced disease and with 
low perspective of renal transplantation. In our opinion 
both techniques, i.e. sPtx and tPtx + AT, have comparable 
results concerning the clinical and laboratory outcome 
and rates of postoperative hypoparathyroidism, at least 
in short- and medium-term follow-up. As regards the 
recurrent disease, even if we did not find significant dif-
ferences between the analysed approaches, it appears 
that tPtx + AT has a “small advantage” in this issue. 
Further randomised control trials and meta-analyses 
are needed to confirm these results.
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